
Sign up to save your podcasts
Or
In this episode, we explore groundbreaking Swedish research on GLP-1 receptor agonists as a potential new treatment for alcohol use disorder. Could diabetes medications like semaglutide revolutionize addiction treatment where traditional therapies have fallen short?
Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.
4.6
267267 ratings
In this episode, we explore groundbreaking Swedish research on GLP-1 receptor agonists as a potential new treatment for alcohol use disorder. Could diabetes medications like semaglutide revolutionize addiction treatment where traditional therapies have fallen short?
Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D.
75 Listeners
152 Listeners
501 Listeners
3,334 Listeners
157 Listeners
1,335 Listeners
719 Listeners
514 Listeners
575 Listeners
16 Listeners
468 Listeners
569 Listeners
724 Listeners
187 Listeners
137 Listeners